Predictors of Toxicity in a Randomized Study of Consolidation Chemoradiation Versus Observation After First Line Chemotherapy in Advanced Gall Bladder Cancers-Reference-Cited by-同舟云学术

Predictors of Toxicity in a Randomized Study of Consolidation Chemoradiation Versus Observation After First Line Chemotherapy in Advanced Gall Bladder Cancers

Published:2024-05 Issue:5 Volume:9 Page:101468
ISSN:2452-1094
Container-title:Advances in Radiation Oncology
language:en
Short-container-title:Advances in Radiation Oncology

Author:

Agrawal Sushma,Gupta Anshika,Kapoor Vishwas,Rahul Rahul,Singh Ashish,Mishra Prabhakar,Saxena Rajan

Funder

Association of Schools and Colleges of Optometry

Conquer Cancer Foundation

Publisher

Elsevier BV

Reference20 articles.

1. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer;Valle;N Engl J Med,2010

2. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer;Oh;NEJM Evid,2022

3. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): A randomised, double-blind, placebo-controlled, phase 3 trial;Kelley;Lancet,2023

4. Chemoradiotherapy versus chemotherapy alone for unresected nonmetastatic gallbladder cancer: National practice patterns and outcomes;Verma;J Natl Compr Canc Netw,2018

5. Consolidation Chemo-radiation improves survival in responders to first line chemotherapy (CT) in locally advanced GBC (LA-GBC);Agrawal;Indian Journal of Cancer,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gallbladder cancer (GBC) with Retroperitoneal Lymphadenopathy (RPLN) have outcomes similar to locally advanced disease if treated with radical intent.;2024-07-02